gadoterate meglumine 376.9 mg/mL
gadoterate meglumine · INJECTION · Slate Run Pharmaceuticals, LLC
gadoterate meglumine is a injection containing gadoterate meglumine at 376.9 mg/mL, taken intravenous. Manufactured by Slate Run Pharmaceuticals, LLC.
Key Facts
- Brand Name
- gadoterate meglumine
- Generic Name
- gadoterate meglumine
- NDC Code (Product)
70436-123- Manufacturer
- Slate Run Pharmaceuticals, LLC
- Strength
- 376.9 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA218073
- Marketing Start
- 06/28/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is gadoterate meglumine used for?
gadoterate meglumine contains gadoterate meglumine. It is a injection taken intravenous. Consult your doctor for specific uses.
Is gadoterate meglumine a controlled substance?
gadoterate meglumine is not classified as a controlled substance by the DEA.
What is the generic name for gadoterate meglumine?
The generic name for gadoterate meglumine is gadoterate meglumine. There are 9 other brand versions of gadoterate meglumine.
What is the NDC code for gadoterate meglumine 376.9 mg/mL?
The NDC (National Drug Code) for gadoterate meglumine 376.9 mg/mL is 70436-123, listed by Slate Run Pharmaceuticals, LLC.
Other Gadoterate Brands
See all →- Gadoterate Meglumine376.9 mg/mL65219-086
- Gadoterate Meglumine376.9 mg/mL65219-088
- CLARISCAN376.9 mg/mL0407-2943
- Gadoterate Meglumine376.9 mg/mL65219-082
- Gadoterate Meglumine376.9 mg/mL65219-084
- DOTAREM376.9 mg/mL67684-2000
- Gadoterate Meglumine376.9 mg/mL65219-080
- DOTAREM376.9 mg/mL67684-3001
- DOTAREM376.9 mg/mL67684-2001
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)